यूरोपीय संघ - अंग्रेज़ी - EMA (European Medicines Agency)

astrazeneca ab - benralizumab - asthma - drugs for obstructive airway diseases, - fasenra is indicated as an add on maintenance treatment in adult patients with severe eosinophilic asthma inadequately controlled despite high-dose inhaled corticosteroids plus long acting β agonists.

यूनाइटेड किंगडम - अंग्रेज़ी - MHRA (Medicines & Healthcare Products Regulatory Agency)

astrazeneca uk ltd - benralizumab - solution for injection - 30mg/1ml

इसराइल - अंग्रेज़ी - Ministry of Health

astrazeneca (israel) ltd - benralizumab - solution for injection - benralizumab 30 mg / 1 ml - benralizumab - fasenra is indicated as an add-on maintenance treatment in adult patients with severe eosinophilic asthma inadequately controlled despite high-dose inhaled corticosteroids plus long-acting β-agonists.

सिंगापुर - अंग्रेज़ी - HSA (Health Sciences Authority)

astrazeneca singapore pte ltd - benralizumab - injection, solution - benralizumab 30 mg/ml

सिंगापुर - अंग्रेज़ी - HSA (Health Sciences Authority)

astrazeneca singapore pte ltd - benralizumab - injection, solution - benralizumab 30 mg / ml

कनाडा - अंग्रेज़ी - Health Canada

astrazeneca canada inc - benralizumab - solution - 30mg - benralizumab 30mg - interleukin antagonists

कनाडा - अंग्रेज़ी - Health Canada

astrazeneca canada inc - benralizumab - solution - 30mg - benralizumab 30mg - interleukin antagonists

सऊदी अरब - अंग्रेज़ी - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

astrazeneca ab, sweden - benralizumab - solution for injection - 30 mg/ml

जॉर्डन - अंग्रेज़ी - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع ادوية شاوي و رشيدات و مسنات - shawi & rushedat drug store - benralizumab 30 mg/1 ml - 30 mg/1 ml

सऊदी अरब - अंग्रेज़ी - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

astrazeneca ab, sweden - benralizumab - solution for injection - 30 mg/ml,